Next-Generation ALK Inhibitors in Non-Small Cell Lung Cancer

2 Visninger
administrator
administrator
07/14/23

Experts discuss the next-generation ALK inhibitors ceritinib and AP26113 as treatments for patients with non-small cell lung cancer.

For more from this discussion, visit http://www.onclive.com/peer-exchange/nsclc-needs

  • Kategori

Vis mere

0 Kommentarer Sorter efter

Ingen kommentarer fundet

Facebook kommentarer

Næste